Çѱ¹ÀÎ Èñ¼Òµ¹±â¾Æ±³¼¼Æ÷Á¾ÀÇ 1p/19q ÀÌÇüÁ¢ÇÕ¼Ò½Ç °Ë»ç¿¡ ÀûÇÕÇÑ Çö¹ÌºÎ¼öü Ç¥ÁöÀÚ
Adequate Microsatellite Markers for 1p/19q Loss of Heterozygosity of Oligodendroglial Tumors in Korean Patients
±è¼¼ÈÆ, ±èŽÂ, ±èÈ£±Ù,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¼¼ÈÆ ( Kim Se-Hoon )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±èŽ ( Kim Tai-Seung )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±èÈ£±Ù ( Kim Ho-Guen )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
KMID : 0357920050390010023
Abstract
Background: It is well known that oligodendrogliomas can be divided into two groups according to the 1p/19q or 1p loss of heterozygosity (LOH) status because oligodendrogliomas with the 1p/19q LOH or the 1p LOH have a better prognosis and chemosensitivity. In this study, we investigated the adequate microsatellite markers for 1p/19q LOH of oligodendroglial tumors in Korean patients.
Methods: We performed PCR that was based on the LOH test with the 1p (D1S508, D1S199, D1S2734, D1S186 & D1S312) and 19q (D19S219, D19S112, D19S412 & D19S596) microsatellite markers; these were the markers that were recommended by other researchers. We performed this PCR on microdissected paraffin embedded tissue blocks of 67 tumors from 56 cases.
Results: The PCR based LOH analysis revealed that 3 microsatellite markers (D1S508, D1S2734 & D1S186) of 1p and 2 markers (D19S219 & D19S412) of 19q had higher heterozygosity scores than other markers. In addition, chromosomal LOH status using these selective markers showed a statistically significant difference of prognosis for oligodendroglial tumors.
Conclusions: We can suggest that the microsatellite markers with high heterozygosity scores (D1S508, D1S2734, D1S186, D19S219 and D19S412) would be adequate microsatellite markers for a PCR based LOH test of oligodendroglial tumors in Korean patients.
Å°¿öµå
Oligodendroglioma;Chromosomes human pair 1;Chromosomes human pair 19;Loss ofheterozygosity;makers microsatellite
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸